J. Goldman & CO LP Ptc Therapeutics, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $11.4 Million - $21.3 Million	-653,284 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $9.46 Million - $13.1 Million	625,104 Added 2218.25%	653,284 $10.9 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $473,705 - $608,969	28,180	28,180 $564,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.